Andrew J Peacock Selected Research

Andrew J Peacock Research Topics

Disease

24	Pulmonary Arterial Hypertension 01/2022 - 06/2008
12	Pulmonary Hypertension 01/2021 - 10/2007
10	Hypoxia (Hypoxemia) 04/2020 - 02/2004
4	Disease Progression 01/2021 - 01/2014
4	Lung Diseases (Lung Disease) 01/2021 - 08/2012
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 04/2017
3	Vascular Remodeling 08/2015 - 10/2007
2	Headache (Headaches) 01/2022 - 01/2021
2	Familial Primary Pulmonary Hypertension 11/2015 - 08/2015
1	Nausea 01/2022
1	Dyspepsia (Indigestion) 01/2021
1	Cough 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Left Ventricular Dysfunction 12/2019
1	Channelopathies 10/2018
1	Hypertension (High Blood Pressure) 07/2017
1	Vascular Diseases (Vascular Disease) 08/2015
1	Anemia 01/2015
1	Edema (Dropsy) 01/2015
1	POEMS Syndrome (Syndrome, POEMS) 12/2014
1	Subdural Hematoma (Subdural Hemorrhage) 03/2013
1	Heart Failure 05/2011
1	Altitude Sickness (Mountain Sickness) 01/2007
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2007

Drug/Important Bio-Agent (IBA)

7	ambrisentan FDA Link 12/2019 - 01/2015
7	p38 Mitogen-Activated Protein KinasesIBA 08/2015 - 08/2004
5	Tadalafil (Cialis)FDA Link 12/2019 - 08/2015
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
3	Imatinib Mesylate (Gleevec)FDA Link 11/2015 - 11/2010
3	Oxygen (Dioxygen)IBA 06/2013 - 02/2004
2	MAP Kinase Kinase Kinase 5IBA 01/2022 - 04/2020
2	Mitogen-Activated Protein KinasesIBA 04/2020 - 01/2006
2	Protein Isoforms (Isoforms)IBA 08/2015 - 01/2006
2	Fluvastatin FDA Link 08/2012 - 10/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 10/2007
2	Serotonin (5 Hydroxytryptamine)IBA 06/2008 - 08/2004
2	EnzymesIBA 01/2006 - 02/2004
1	selonsertibIBA 01/2022
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	Epoprostenol ReceptorsIBA 01/2021
1	hydralazine 4-anisaldehyde hydrazoneIBA 01/2021
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	riociguatIBA 01/2021
1	CytokinesIBA 04/2020
1	Semaxinib (SU5416)IBA 04/2020
1	Carbon MonoxideIBA 01/2020
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	PotassiumIBA 10/2018
1	ApelinIBA 04/2018
1	Dobutamine FDA LinkGeneric 04/2017
1	Peptides (Polypeptides)IBA 11/2015
1	pro-brain natriuretic peptide (1-76)IBA 11/2015
1	Vasodilator Agents (Vasodilators)IBA 11/2015
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 08/2015
1	MonocrotalineIBA 08/2015
1	Endothelin A ReceptorIBA 01/2015
1	Endothelin Receptor AntagonistsIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014
1	Platelet-Derived Growth FactorIBA 03/2013
1	MitogensIBA 08/2012
1	Nitrous Oxide (Laughing Gas)IBA 05/2011
1	Superoxides (Superoxide)IBA 05/2009
1	Dexfenfluramine (Redux)IBA 06/2008
1	AminorexIBA 06/2008
1	Dimethylallyltranstransferase (Dimethylallyltransferase)IBA 10/2007
1	Proteins (Proteins, Gene)FDA Link 10/2007
1	Simvastatin (Zocor)FDA LinkGeneric 10/2007
1	CholesterolIBA 10/2007
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2007
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 08/2004
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 02/2004
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2004
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 02/2004
1	Endothelin-1 (Endothelin 1)IBA 02/2004
1	AngiotensinsIBA 02/2004

Therapy/Procedure

20	Therapeutics 01/2021 - 05/2008
1	Subcutaneous Injections 04/2020
1	Radiotherapy 12/2014
1	Endarterectomy (Thromboendarterectomy) 05/2008
1	Catheters 03/2008